EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Probiotics in inflammatory bowel disease: microbial modulation and therapeutic prospects

Omar P Vallejos, Susan M Bueno, Alexis M Kalergis

Trends in Molecular Medicine · 2025-08 · 31 (8) · 731-742

DOI: 10.1016/j.molmed.2024.12.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Molecular Medicine, 2025-08. Verfasst von Omar P Vallejos und 2 weiteren Autor:innen. Beteiligte Einrichtung: Millennium Institute of Immunology and Immunotherapy, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile. Hauptthemen laut MEDLINE: Probiotics, Inflammatory Bowel Diseases, Gastrointestinal Microbiome. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: Fondo Nacional de Desarrollo Científico y Tecnológico, Pontificia Universidad Católica de Chile, National Agency for Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is a chronic inflammatory disorder that represents a significant public health challenge worldwide. This multifactorial condition results from complex interactions among genetic, environmental, immune, and microbial factors. Some beneficial microbes, known as probiotics, have been identified as promising therapeutic agents for inflammatory conditions, such as IBD. In this review, we explore the potential of probiotics as a therapeutic strategy for managing IBD. Probiotics have shown promise due to their ability to modulate the gut microbiota, regulate histamine levels, and enhance vitamin D metabolism, thereby promoting a tolerant immune profile and reducing inflammation. While the exact mechanisms underlying these benefits remain incompletely understood, probiotics represent a novel and emerging approach for alleviating the exacerbated inflammation characteristic of this disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsInflammatory Bowel DiseasesGastrointestinal MicrobiomeHumansAnimalsVitamin D

Stichwörter der Autor:innen

IBDdysbiosishistamineinflammationprobioticsvitamin D

Substanzen

Vitamin D

Autor:innen und Institutionen

  • Millennium Institute of Immunology and Immunotherapy, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Millennium Institute of Immunology and Immunotherapy, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile. Electronic address: sbuenor@uc.cl.
  • Millennium Institute of Immunology and Immunotherapy, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile; Departamento de Endocrinología, Facultad de Medicina, Pontificia Universi…

Förderung

  • Fondo Nacional de Desarrollo Científico y Tecnológico
  • Pontificia Universidad Católica de Chile
  • National Agency for Research and Development

Zitieren

APA

Vallejos, O. P., Bueno, S. M., & Kalergis, A. M. (2025). Probiotics in inflammatory bowel disease: microbial modulation and therapeutic prospects. Trends in Molecular Medicine, 31(8), 731-742. https://doi.org/10.1016/j.molmed.2024.12.005

Vancouver

Vallejos OP, Bueno SM, Kalergis AM. Probiotics in inflammatory bowel disease: microbial modulation and therapeutic prospects. Trends in Molecular Medicine. 2025;31(8):731-742. doi:10.1016/j.molmed.2024.12.005

BibTeX
@article{Vallejos2025,
  author = {Vallejos, Omar P and Bueno, Susan M and Kalergis, Alexis M},
  title = {Probiotics in inflammatory bowel disease: microbial modulation and therapeutic prospects},
  journal = {Trends in Molecular Medicine},
  year = {2025},
  volume = {31},
  number = {8},
  pages = {731--742},
  doi = {10.1016/j.molmed.2024.12.005}
}
Kostenlos starten →